Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 620
2021 473
2022 165
2023 69
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,186 results

Results by year

Filters applied: . Clear all
Page 1
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyciński J, Lorzadeh S, Kotfis K, Ghavami S, Łos MJ. Drożdżal S, et al. Drug Resist Updat. 2021 Dec;59:100794. doi: 10.1016/j.drup.2021.100794. Epub 2021 Dec 9. Drug Resist Updat. 2021. PMID: 34991982 Free PMC article. Review.
Various agents were initially proclaimed to be effective against SARS-CoV-2, the etiological agent of COVID-19. Hydroxychloroquine, lopinavir/ritonavir, and ribavirin are all examples of therapeutic agents, whose efficacy against COVID …
Various agents were initially proclaimed to be effective against SARS-CoV-2, the etiological agent of COVID-1 …
COVID-19 and lung pathologies.
Purohit D, Ahirwar AK, Sakarde A, Asia P, Gopal N. Purohit D, et al. Horm Mol Biol Clin Investig. 2021 Aug 2;42(4):435-443. doi: 10.1515/hmbci-2020-0096. Horm Mol Biol Clin Investig. 2021. PMID: 34333882 Review.
COVID-19 is a global emergency with over 10 million cases and over 500, 000 deaths worldwide. The SARS CoV-2 is a RNA virus belonging to the family coronaviridae. ...
COVID-19 is a global emergency with over 10 million cases and over 500, 000 deaths worldwide. The SARS CoV …
COVID-19 challenges and its therapeutics.
Rehman SU, Rehman SU, Yoo HH. Rehman SU, et al. Biomed Pharmacother. 2021 Oct;142:112015. doi: 10.1016/j.biopha.2021.112015. Epub 2021 Aug 5. Biomed Pharmacother. 2021. PMID: 34388532 Free PMC article. Review.
COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the severe public health issues in recent decades. nCoV, the novel SARS coronavirus that causes COVID-19, has brought to …
COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the seve …
Neutrophil autophagy and NETosis in COVID-19: perspectives.
Zhang R, Sun C, Han Y, Huang L, Sheng H, Wang J, Zhang Y, Lai J, Yuan J, Chen X, Jiang C, Wu F, Wang J, Fan X, Wang J. Zhang R, et al. Autophagy. 2023 Mar;19(3):758-767. doi: 10.1080/15548627.2022.2099206. Epub 2022 Aug 11. Autophagy. 2023. PMID: 35951555 Free PMC article. Review.
The SARS-CoV-2 pathogen is the cause of various systemic diseases, mainly acute pneumonia. ...This review keeps up with the latest research on COVID-19 from neutrophil autophagy and NETosis with a new perspective, which can guide the urgent deve …
The SARS-CoV-2 pathogen is the cause of various systemic diseases, mainly acute pneumonia. ...This review keeps up with …
Emerging treatment strategies for COVID-19 infection.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis IG, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Clin Exp Med. 2021 May;21(2):167-179. doi: 10.1007/s10238-020-00671-y. Epub 2020 Oct 30. Clin Exp Med. 2021. PMID: 33128197 Free PMC article. Review.
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused by SARS-CoV-2 characterized as …
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and has led to a w …
An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
Khade SM, Yabaji SM, Srivastava J. Khade SM, et al. Prep Biochem Biotechnol. 2021;51(7):650-658. doi: 10.1080/10826068.2020.1848869. Epub 2020 Nov 23. Prep Biochem Biotechnol. 2021. PMID: 33226885 Review.
The causative agent of novel coronavirus disease (COVID-19) is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 possesses RNA as a genetic material …
The causative agent of novel coronavirus disease (COVID-19) is severe acute respiratory syndrom …
Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API).
Barbosa AN, Chebabo A, Starling C, Pérez C, Cunha CA, de Luna D, Nunes EP, Zambrano G, Ferreira JC, Croda J, Falavigna M, Gomes-da-Silva MM, Thormann M, Cimerman S, Parahiba SM, Tanni S, Bernardo WM, Rodriguez-Morales AJ. Barbosa AN, et al. Ann Clin Microbiol Antimicrob. 2023 Aug 7;22(1):67. doi: 10.1186/s12941-023-00623-w. Ann Clin Microbiol Antimicrob. 2023. PMID: 37550690 Free PMC article. Review.
BACKGROUND: Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. ...Questions were formulated regarding prophylaxis and treatment of COVID- …
BACKGROUND: Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been in …
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group; Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8. N Engl J Med. 2020. PMID: 33031652 Free PMC article. Clinical Trial.
BACKGROUND: Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials. ...CONCLUSIONS: Among patients ho …
BACKGROUND: Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid- …
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.
Aljadeed R. Aljadeed R. J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28. J Pharm Pract. 2022. PMID: 33906514 Review.
On March 11th, the World Health Organization (WHO) announced the unprecedented outbreak of "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2) to be a pandemic. Thus far, COVID-19 has infected …
On March 11th, the World Health Organization (WHO) announced the unprecedented outbreak of "severe acute respiratory …
COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail.
Pal R, Bhasin MK, Bhadada SK. Pal R, et al. Infect Disord Drug Targets. 2021;21(5):e270421186842. doi: 10.2174/1871526520666201013160803. Infect Disord Drug Targets. 2021. PMID: 33050869
The novel coronavirus disease (COVID-19) is on the rampage claiming over 297000 lives globally. ...Till date, there exists no effective vaccine or therapy against COVID-19. However, with limited clinical data, HCQ is being used for treatm …
The novel coronavirus disease (COVID-19) is on the rampage claiming over 297000 lives globally. ...Till date, there exi …
1,186 results